IL-31 associated with coronary artery lesion formation in Kawasaki disease

Wan Ning Tseng, Mao Hung Lo, Mindy Ming Huey Guo, Kai Sheng Hsieh, Wei Chiao Chang, Ho Chang Kuo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Kawasaki disease (KD) is known to be associated with T help (Th) 2 reaction and subsequently allergic diseases. Interleukin-31 (IL-31) has also been reported to be involved in Th2 mediated diseases such as allergic diseases. However, the role of IL-31 in KD has not been previously reported. The aim of this study is to investigate whether IL-31 is associated with KD and its clinical outcome. Material: A total of 78 KD patients who met the criteria of KD were enrolled in this study as well as 20 age-matched controls. Plasma samples were conducted to measure IL-31 before intravenous immunoglobulin (IVIG) treatment (KD1), within 3 days after IVIG treatment (KD2) and at least 3 weeks after IVIG treatment (KD3) by utilizing enzyme-linked immunosorbent assay (ELISA). Result: Our findings showed that IL-31 expression was higher in KD patients after IVIG treatment significantly (KD2>KD1: 1265.0±199.3 vs. 840.2∓152.5 pg/ml, p

Original languageEnglish
Article numbere105195
JournalPLoS One
Volume9
Issue number8
DOIs
Publication statusPublished - Aug 14 2014

Fingerprint

Mucocutaneous Lymph Node Syndrome
Interleukins
coronary vessels
interleukins
Coronary Vessels
Intravenous Immunoglobulins
immunoglobulins
Therapeutics
enzyme-linked immunosorbent assay
Immunosorbents
Hypersensitivity
Enzyme-Linked Immunosorbent Assay
Assays
Plasmas
sampling

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Tseng, W. N., Lo, M. H., Guo, M. M. H., Hsieh, K. S., Chang, W. C., & Kuo, H. C. (2014). IL-31 associated with coronary artery lesion formation in Kawasaki disease. PLoS One, 9(8), [e105195]. https://doi.org/10.1371/journal.pone.0105195

IL-31 associated with coronary artery lesion formation in Kawasaki disease. / Tseng, Wan Ning; Lo, Mao Hung; Guo, Mindy Ming Huey; Hsieh, Kai Sheng; Chang, Wei Chiao; Kuo, Ho Chang.

In: PLoS One, Vol. 9, No. 8, e105195, 14.08.2014.

Research output: Contribution to journalArticle

Tseng, Wan Ning ; Lo, Mao Hung ; Guo, Mindy Ming Huey ; Hsieh, Kai Sheng ; Chang, Wei Chiao ; Kuo, Ho Chang. / IL-31 associated with coronary artery lesion formation in Kawasaki disease. In: PLoS One. 2014 ; Vol. 9, No. 8.
@article{dcaead0f4bf740368830a8a114c16dd4,
title = "IL-31 associated with coronary artery lesion formation in Kawasaki disease",
abstract = "Background: Kawasaki disease (KD) is known to be associated with T help (Th) 2 reaction and subsequently allergic diseases. Interleukin-31 (IL-31) has also been reported to be involved in Th2 mediated diseases such as allergic diseases. However, the role of IL-31 in KD has not been previously reported. The aim of this study is to investigate whether IL-31 is associated with KD and its clinical outcome. Material: A total of 78 KD patients who met the criteria of KD were enrolled in this study as well as 20 age-matched controls. Plasma samples were conducted to measure IL-31 before intravenous immunoglobulin (IVIG) treatment (KD1), within 3 days after IVIG treatment (KD2) and at least 3 weeks after IVIG treatment (KD3) by utilizing enzyme-linked immunosorbent assay (ELISA). Result: Our findings showed that IL-31 expression was higher in KD patients after IVIG treatment significantly (KD2>KD1: 1265.0±199.3 vs. 840.2∓152.5 pg/ml, p",
author = "Tseng, {Wan Ning} and Lo, {Mao Hung} and Guo, {Mindy Ming Huey} and Hsieh, {Kai Sheng} and Chang, {Wei Chiao} and Kuo, {Ho Chang}",
year = "2014",
month = "8",
day = "14",
doi = "10.1371/journal.pone.0105195",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - IL-31 associated with coronary artery lesion formation in Kawasaki disease

AU - Tseng, Wan Ning

AU - Lo, Mao Hung

AU - Guo, Mindy Ming Huey

AU - Hsieh, Kai Sheng

AU - Chang, Wei Chiao

AU - Kuo, Ho Chang

PY - 2014/8/14

Y1 - 2014/8/14

N2 - Background: Kawasaki disease (KD) is known to be associated with T help (Th) 2 reaction and subsequently allergic diseases. Interleukin-31 (IL-31) has also been reported to be involved in Th2 mediated diseases such as allergic diseases. However, the role of IL-31 in KD has not been previously reported. The aim of this study is to investigate whether IL-31 is associated with KD and its clinical outcome. Material: A total of 78 KD patients who met the criteria of KD were enrolled in this study as well as 20 age-matched controls. Plasma samples were conducted to measure IL-31 before intravenous immunoglobulin (IVIG) treatment (KD1), within 3 days after IVIG treatment (KD2) and at least 3 weeks after IVIG treatment (KD3) by utilizing enzyme-linked immunosorbent assay (ELISA). Result: Our findings showed that IL-31 expression was higher in KD patients after IVIG treatment significantly (KD2>KD1: 1265.0±199.3 vs. 840.2∓152.5 pg/ml, p

AB - Background: Kawasaki disease (KD) is known to be associated with T help (Th) 2 reaction and subsequently allergic diseases. Interleukin-31 (IL-31) has also been reported to be involved in Th2 mediated diseases such as allergic diseases. However, the role of IL-31 in KD has not been previously reported. The aim of this study is to investigate whether IL-31 is associated with KD and its clinical outcome. Material: A total of 78 KD patients who met the criteria of KD were enrolled in this study as well as 20 age-matched controls. Plasma samples were conducted to measure IL-31 before intravenous immunoglobulin (IVIG) treatment (KD1), within 3 days after IVIG treatment (KD2) and at least 3 weeks after IVIG treatment (KD3) by utilizing enzyme-linked immunosorbent assay (ELISA). Result: Our findings showed that IL-31 expression was higher in KD patients after IVIG treatment significantly (KD2>KD1: 1265.0±199.3 vs. 840.2∓152.5 pg/ml, p

UR - http://www.scopus.com/inward/record.url?scp=84905962548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905962548&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0105195

DO - 10.1371/journal.pone.0105195

M3 - Article

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e105195

ER -